Licence changes and product updates news

RSS

February 2010

The breast cancer treatment Herceptin (trastuzumab) has been approved for the treatment...

Patients with chronic kidney disease and hyperphosphataemia can now be treated with...

Prescribing advice for phenytoin has been updated to reflect new evidence about...

The following products have been discontinued from the UK market this year....

The Committee for Medicinal Products for Human Use (CHMP) has recommended that...

Micardis (telmisartan) can now be prescribed for the prevention of cardiovascular morbidity...

Tritace (ramipril) is now licensed for the treatment of incipient glomerular diabetic...

Januvia ( sitagliptin ) can now be prescribed as an add-on to...

Procoralan (ivabradine) may now be prescribed in combination with beta-blockers in patients...

Safety issues surrounding the use of warfarin have been reviewed by the...

Prescribing information for methylphenidate is being updated following a review of the...

Educational resource for the learning and teaching of the
GP curriculum

Cumulative list of products discontinued from the UK market
in 2010

Healthcare Republic resource centre for diagnosing and managing psoriasis

Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.